Introduction: Haemodiafiltration (HDF) has been reported to improve erythropoietin (EPO) responsiveness and phosphate clearance. We prospectively audited the effect of HDF on EPO dosages, weight and serum phosphate. Methods: 34 patients dialyzing on Tu/Th/Sa switched to HDF, and 44 dialyzing on M/W/F remained on high-flux haemodialysis (HD) and were followed for 12 months. Results: Dialysis adequacy (Kt/V start HDF 1.56 ± 0.03 vs. HD 1.58 ± 0.04 and 12 months 1.55 ± 0.03 vs. 1.59 ± 0.03), haemoglobin (start 11.7 ± 0.3 vs. 11,8 ± 0.2 g/dl and end 11.5 ± 0.1 vs. 11.3 ± 0.3 g/dl), weight (start 69.8 ± 2.4 vs. 67.8 ± 2.5 kg and end 67.4 ± 2.5 vs. 66.1 ± 2.3 kg), or EPO prescription (start 83 (61–186) vs. 123 (71–225) IU/kg/weeks and 12 months 142 (48–188) vs. 124 (59–223) IU/kg/weeks) did not differ. There were no differences in serum albumin, CRP, calcium and parathyroid hormone. Serum beta-2-microglobulin (B2M) decreased with HDF (32.7 ± 1.9 vs. 28.1 ± 1.1 mg/l, p < 0.01), but not with HD (31.6 ± 1.4 vs. 31.5 ± 1.1 mg/l). Serum phosphate fell with HDF (start 1.48 ± 0.08 vs. 1.57 ± 0.07 mmol/l (p = NS); 3 months 1.35 ± 0.07 vs. 1.61 ± 0.08; 6 months 1.34 ± 0.06 vs. 1.57 ± 0.06, and 12 months 1.36 ± 0.07 vs. 1.67 ± 0.07, all p < 0.05). Conclusion: HDF did not lead to weight gain or improved EPO responsiveness in this prospective observational study. However, predialysis serum phosphate and B2M fell with HDF.

Davenport A: The techniques of haemofiltraton and haemodiafiltration. J Ren Nurs 2009;1:191–195.
Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W: A comparison of on-line haemodiafiltration and high-flux haemodialysis: a prospective clinical study. J Am Soc Nephrol 2000;11:2344–2350.
Davenport A, Farrington K: Dialysis dose in acute kidney injury and chronic dialysis. Lancet 2010;375:705–706.
Blankestijn PJ, Ledebo I, Canaud B: Haemodiafiltration: clinical evidence and remaining questions. Kidney Int 2010;77:581–587.
Effect of increased convective clearance by on-line haemodiafiltration on all cause and cardiovascular mortality in chroni haemodialysis patients: The Dutch Convective Transport Study (CONTRAST). (accessed November 2010).
Comparison of post-dilution on-line haemodiafiltration and haemodialysis (Turkish HDF Study). (accessed November 2010).
Savica V, Ciolino F, Monardo P, Mallamace A, Savica R, Santoro D, Bellinghieri G: Nutritional status in haemodialysis patients: options for on-line convective treatment. J Ren Nutr 2006;16:237–240.
Schiffl H: Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. Eur J Med Res 2007;12:26–33.
Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Lévesque R, Nubé MJ, Bots ML, Blankestijn PJ, ter Wee PM, CONTRAST Investigators: Short-term effects of online haemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 2010;55:77–87.
Davenport A, Gardner C, Delaney M; Pan Thames Renal Audit Group: The effect of dialysis modality on phosphate control: haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit. Nephrol Dial Transplant 2010;25:897–901.
Bonforte G, Grillo P, Zerbi S, Surian M: Improvement of anemia in haemodialysis patients treated by haemodiafiltration with high-volume on-line-prepared substitution fluid. Blood Purif 2002;20:357–363.
Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gauly A, Passlick-Deetjen J: On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purif 2006;24:163–173.
Basile C, Giordano R, Montanaro A, De Maio PD, De Padova FD, Marangi AL, Semeraro A: Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study. Nephrol Dial Transplant 2001;16:1914–1919.
Bossola M, Muscaritoli M, Tazza L, Giungi S, Panocchia N, Rossi Fanelli F, Luciani G: Switch from bicarbonate haemodialysis to haemodiafiltration with online regeneration of the ultrafiltrate (HFR): effects on nutritional status, microinflammation, and beta-microglobulin. Artif Organs 2005;29:259–263.
Ledebo I: Purification of dialysis fluid: historical background and perspective. Blood Purif 2009;27(suppl 1):17–19.
Davenport A: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton) 2009;14:455–461.
Morey B, Walker R, Davenport A: More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients. Nephron Clin Pract 2008;109:c173–c180.
Renal Association Clinical Practice Guidelines, ed 4. Module 2, complications. (accessed November 2010).
Munoz R, Gallardo I, Valladares E, Saracho R, Martinez I, Ocharan J, Montenegro J: Online haemodiafiltration: 4 years of clinical experience. Hemodial Int 2006;10(suppl 1):S28–S32.
Pickett TM, Cruickshank A, Greenwood RN, Taube D, Davenport A, Farrington K: Membrane flux not biocompatibility determines beta-2-microglobulin levels in hemodialysis patients. Blood Purif 2002;20:161–166.
Davenport A: Membrane designs and composition for haemodialysis, haemofiltration and haemodialfiltration: past, present and future. Minerva Urol Nefrol 2010;62:29–40.
Wizemann V, Lotz C, Techert F, Uthoff S: On-line haemodiafiltration versus low-flux haemodialysis: a prospective randomized study. Nephrol Dial Transplant 2000;15(suppl 1):43–48.
Davenport A, Gardner C, Delaney M: Do differences in dialysis prescription impact on KDOQI bone mineral targets? The Pan Thames Renal Audit. Blood Purif 2010;30:111–117.
Maduell F, Navarro V, Torregrosa E, Rius A, Dicenta F, Cruz MC, Ferrero JA: Change from three times a week on-line hemodiafiltration to short daily on-line haemodiafiltration. Kidney Int 2003;64:305–313.
Walsh M, Manns BJ, Klarenbach S, Tonelli M, Hemmelgarn B, Culleton B: The effects of nocturnal compared with conventional haemodialysis on mineral metabolism: a randomized-controlled trial. Hemodial Int 2010;14:174–181.
Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998;31:607–617.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.